Gene Therapy on Chaolangiocarcinoma with Herpes Simplex Virus Thymidine Kinase and Cytosine Deami-Nase Gene in Vivo and in Vitro

李梅生,梁力建,黄洁夫,陈祖兵
DOI: https://doi.org/10.3760/j.issn:1001-9030.2004.12.006
2004-01-01
Abstract:Objective To investigate the antitumor activity of Herpes simplex virus thymidine kinase and cytosine deaminase gene (HSV tk/CD) fusion gene on cholangiocarcinoma.Methods Cholangiocarcinoma cells were transinfected with HSV tk/CD fusion gene guided by adenovirus in vitro.Inhibiting rate of tumor cell growth and BSE were observed in comparoson with that with single suicide gene.On this bases,animal model with cholangiocarcinoma transplanted subcutaneously was developed.After bing injected with the recombinant virus into the tumors,the growth of tumor were monitored regularly.Results In comparison with simgle suicide gene system,this double gene system exerted higher sensitivity.When prodrugs were given in same concentration,tumor growth in the experimental groups was inhibited to varying degrees.The survival rate of tumor cells in the double gene group,the CD group and the TK group was 3.1%, 32.1%, 55.2% respectively.In comparison with the control group,the inhibiting rate in the experimental groups was 41.2%, 55.7% and 70.0% respectively ( P 0.05). Histological examination revealed that obvious necrosis was seen in the experimental groups,particularly in the group transinfected with pAd (HSV tk/CD).Conclusion Fusion gene system has strong antitumor effect on cholangiocarcinoma in vitro and in vivo.
What problem does this paper attempt to address?